Hepatitis E vaccine

被引：31

作者：

Aggarwal, Rakesh ^{[2
]}

Jameel, Shahid ^{[1
]}

机构：

[1] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India

[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India

来源：

HEPATOLOGY INTERNATIONAL | 2008年 / 2卷 / 03期

关键词：

hepatitis; hepatitis E; HEV; vaccine;

D O I：

10.1007/s12072-008-9071-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatitis E is an emerging disease in resource-poor regions of the world. It is estimated that about 2 billion people live in areas endemic for this disease. The inability to reproducibly culture hepatitis E virus makes it impossible to develop traditional live or inactivated vaccines. However, significant progress has been made in developing and testing recombinant subunit vaccines based on the viral capsid protein. This review summarizes these efforts.

引用

页码：308 / 315

页数：8

共 65 条

[41] Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes [J].

Niikura, M ;

Takamura, S ;

Kim, G ;

Kawai, S ;

Saijo, M ;

Morikawa, S ;

Kurane, I ;

Li, TC ;

Takeda, N ;

Yasutomi, Y .

VIROLOGY, 2002, 293 (02) :273-280

[42] The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious [J].

Panda, SK ;

Ansari, IH ;

Durgapal, H ;

Agrawal, S ;

Jameel, S .

JOURNAL OF VIROLOGY, 2000, 74 (05) :2430-2437

[43] Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine [J].

Purcell, RH ;

Nguyen, H ;

Shapiro, M ;

Engle, RE ;

Govindarajan, S ;

Blackwelder, WC ;

Wong, DC ;

Prieels, JP ;

Emerson, SU .

VACCINE, 2003, 21 (19-20) :2607-2615

[44] PRELIMINARY EVIDENCE THAT A TRPE-HEV FUSION PROTEIN PROTECTS CYNOMOLGUS MACAQUES AGAINST CHALLENGE WITH WILD-TYPE HEPATITIS-E VIRUS (HEV) [J].

PURDY, MA ;

MCCAUSTLAND, KA ;

KRAWCZYNSKI, K ;

SPELBRING, J ;

REYES, GR ;

BRADLEY, DW .

JOURNAL OF MEDICAL VIROLOGY, 1993, 41 (01) :90-94

[45] ISOLATION OF A CDNA FROM THE VIRUS RESPONSIBLE FOR ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS [J].

REYES, GR ;

PURDY, MA ;

KIM, JP ;

LUK, KC ;

YOUNG, LM ;

FRY, KE ;

BRADLEY, DW .

SCIENCE, 1990, 247 (4948) :1335-1339

[46] Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells [J].

Robinson, RA ;

Burgess, WH ;

Emerson, SU ;

Leibowitz, RS ;

Sosnovtseva, SA ;

Tsarev, S ;

Purcell, RH .

PROTEIN EXPRESSION AND PURIFICATION, 1998, 12 (01) :75-84

[47] Perspectives of vaccination against hepatitis E [J].

Safary, A .

INTERVIROLOGY, 2001, 44 (2-3) :162-166

[48] Genetic heterogeneity of hepatitis E virus [J].

Schlauder, GG ;

Mushahwar, IK .

JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (02) :282-292

[49] Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein [J].

Schofield, DJ ;

Glamann, J ;

Emerson, SU ;

Purcell, RH .

JOURNAL OF VIROLOGY, 2000, 74 (12) :5548-5555

[50] Purification and diagnostic utility of a recombinant hepatitis E virus capsid protein expressed in insect larvae [J].

Sehgal, D ;

Malik, PS ;

Jameel, S .

PROTEIN EXPRESSION AND PURIFICATION, 2003, 27 (01) :27-34

← 1 2 3 4 5 6 7 →